Ind-Swift Ltd

Ind-Swift Ltd

₹ 30.3 0.63%
11 Dec 4:00 p.m.
About

Incorporated in 1986, Ind-Swift Ltd deals in manufacturing and exporting of pharmaceutical products

Key Points

Business Overview:[1]
Company has expertise in finished goods dosage, Active Pharmaceutical Ingredients (API’s) and herbal products. Company also diversified into multiple fields viz., Infrastructure, Printing, Packaging & Stationary, Education, and Media Publication with its every unit as an independent profit earning center

  • Market Cap 165 Cr.
  • Current Price 30.3
  • High / Low 32.6 / 14.3
  • Stock P/E 3.00
  • Book Value -122
  • Dividend Yield 0.00 %
  • ROCE 13.4 %
  • ROE %
  • Face Value 2.00

Pros

Cons

  • The company has delivered a poor sales growth of 11.7% over past five years.
  • Contingent liabilities of Rs.72.4 Cr.
  • Earnings include an other income of Rs.93.8 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
97.37 104.35 105.57 94.67 103.82 106.59 105.88 148.54 115.92 102.56 135.23 113.85 136.35
84.68 92.32 95.59 89.55 92.77 88.69 97.93 130.14 104.78 98.07 120.74 110.63 121.94
Operating Profit 12.69 12.03 9.98 5.12 11.05 17.90 7.95 18.40 11.14 4.49 14.49 3.22 14.41
OPM % 13.03% 11.53% 9.45% 5.41% 10.64% 16.79% 7.51% 12.39% 9.61% 4.38% 10.72% 2.83% 10.57%
5.62 4.06 7.08 1.51 0.87 3.20 66.86 5.63 3.15 2.62 46.59 39.93 4.63
Interest 15.30 14.14 14.24 15.06 15.38 14.84 14.48 14.95 18.26 15.30 14.43 9.54 9.53
Depreciation 7.95 7.99 8.30 7.01 7.13 7.29 7.24 6.72 6.73 6.78 6.88 5.37 5.39
Profit before tax -4.94 -6.04 -5.48 -15.44 -10.59 -1.03 53.09 2.36 -10.70 -14.97 39.77 28.24 4.12
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.61% 0.00% 0.00%
-4.94 -6.04 -5.48 -15.44 -10.59 -1.03 53.10 2.36 -10.71 -14.97 37.54 28.24 4.11
EPS in Rs -0.91 -1.12 -1.01 -2.85 -1.96 -0.19 9.80 0.44 -1.98 -2.76 6.93 5.21 0.76
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 9m Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
393 570 417 308 263 270 289 330 356 398 411 502 488
411 602 487 465 328 262 278 306 315 352 369 448 451
Operating Profit -18 -32 -70 -157 -65 8 11 23 41 45 42 54 37
OPM % -4% -6% -17% -51% -25% 3% 4% 7% 12% 11% 10% 11% 8%
2 11 2 13 -246 -20 34 22 14 24 72 53 94
Interest 86 77 40 19 16 7 3 29 52 57 60 63 49
Depreciation 18 26 39 36 36 35 34 34 33 32 29 27 24
Profit before tax -121 -124 -147 -200 -363 -53 8 -17 -29 -20 26 16 57
Tax % -8% -7% -2% 0% 0% 1% 0% 15% 1% 2% 0% 14%
-111 -116 -145 -200 -364 -54 8 -19 -30 -20 26 14 55
EPS in Rs -24.10 -22.95 -28.83 -39.71 -67.25 -9.99 1.51 -3.53 -5.51 -3.70 4.81 2.63 10.14
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -1%
5 Years: 12%
3 Years: 12%
TTM: 2%
Compounded Profit Growth
10 Years: 6%
5 Years: -7%
3 Years: 5%
TTM: 426%
Stock Price CAGR
10 Years: 16%
5 Years: 59%
3 Years: 36%
1 Year: 80%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 9 10 10 10 11 11 11 11 11 11 11 11 11
Reserves 194 84 -64 -264 -636 -690 -688 -724 -706 -731 -716 -702 -669
985 1,024 1,054 1,061 1,062 1,055 1,010 1,017 1,023 1,036 993 1,014 1,023
219 272 228 254 232 237 265 298 344 316 361 331 321
Total Liabilities 1,407 1,390 1,228 1,061 669 613 598 602 672 632 649 654 686
421 440 404 374 342 311 291 270 244 236 216 184 166
CWIP 37 4 4 4 2 0 0 0 13 9 30 51 56
Investments 45 45 45 45 44 44 41 24 70 64 54 1 1
905 900 775 638 281 258 267 308 344 323 349 418 461
Total Assets 1,407 1,390 1,228 1,061 669 613 598 602 672 632 649 654 686

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-146 103 86 -106 7 1 43 35 83 50 73 15
-28 -14 -6 -4 -4 -3 -14 -11 -17 -18 -29 77
146 -89 -81 110 -11 -4 -13 -26 -54 -45 -47 -42
Net Cash Flow -28 0 -1 0 -8 -5 16 -3 12 -13 -3 50

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 338 282 425 451 151 113 95 104 111 83 93 111
Inventory Days 418 202 117 151 86 108 112 102 123 120 150 83
Days Payable 179 152 155 290 356 426 454 440 454 353 393 262
Cash Conversion Cycle 577 331 387 311 -119 -206 -246 -234 -220 -149 -150 -68
Working Capital Days 554 317 325 409 -37 -57 -99 -79 -94 -69 -77 -27
ROCE % -4% -10% -20% -14% -4% -4% 2% 8% 11% 8% 13%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
55.55% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58%
44.44% 44.42% 44.42% 44.42% 44.40% 44.42% 44.42% 44.42% 44.42% 44.42% 44.42% 44.42%
No. of Shareholders 13,59614,00914,29614,42214,92714,78514,59013,74514,21916,43817,44018,028

Documents